CAMTEK LTD (CAMT) Fundamental Analysis & Valuation

NASDAQ:CAMT • IL0010952641

147.31 USD
-17.72 (-10.74%)
At close: Mar 6, 2026
147.31 USD
0 (0%)
After Hours: 3/6/2026, 8:04:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CAMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CAMT. CAMT was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and the financial health of CAMT get a neutral evaluation. Nothing too spectacular is happening here. CAMT shows excellent growth, but is valued quite expensive already. These ratings would make CAMT suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. CAMT Profitability Analysis

1.1 Basic Checks

  • CAMT had positive earnings in the past year.
  • Each year in the past 5 years CAMT has been profitable.
  • Of the past 5 years CAMT 4 years had a positive operating cash flow.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • CAMT has a Return On Assets of 4.03%. This is in the better half of the industry: CAMT outperforms 61.74% of its industry peers.
  • With a decent Return On Equity value of 8.22%, CAMT is doing good in the industry, outperforming 67.83% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 8.82%, CAMT is doing good in the industry, outperforming 77.39% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CAMT is in line with the industry average of 10.50%.
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROIC 8.82%
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a decent Profit Margin value of 10.22%, CAMT is doing good in the industry, outperforming 66.09% of the companies in the same industry.
  • CAMT's Profit Margin has declined in the last couple of years.
  • CAMT has a Operating Margin of 25.94%. This is amongst the best in the industry. CAMT outperforms 84.35% of its industry peers.
  • In the last couple of years the Operating Margin of CAMT has grown nicely.
  • CAMT has a better Gross Margin (50.56%) than 63.48% of its industry peers.
  • In the last couple of years the Gross Margin of CAMT has remained more or less at the same level.
Industry RankSector Rank
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CAMT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CAMT is destroying value.
  • The number of shares outstanding for CAMT has been increased compared to 1 year ago.
  • The number of shares outstanding for CAMT has been increased compared to 5 years ago.
  • CAMT has a worse debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • CAMT has an Altman-Z score of 8.96. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
  • CAMT has a Altman-Z score of 8.96. This is in the better half of the industry: CAMT outperforms 70.43% of its industry peers.
  • CAMT has a Debt/Equity ratio of 0.84. This is a neutral value indicating CAMT is somewhat dependend on debt financing.
  • CAMT has a worse Debt to Equity ratio (0.84) than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 8.96
ROIC/WACC0.72
WACC12.2%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 8.35 indicates that CAMT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 8.35, CAMT belongs to the top of the industry, outperforming 86.09% of the companies in the same industry.
  • CAMT has a Quick Ratio of 7.31. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • CAMT has a Quick ratio of 7.31. This is amongst the best in the industry. CAMT outperforms 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 8.35
Quick Ratio 7.31
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. CAMT Growth Analysis

3.1 Past

  • CAMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.23%, which is quite good.
  • The Earnings Per Share has been growing by 38.06% on average over the past years. This is a very strong growth
  • The Revenue has grown by 15.65% in the past year. This is quite good.
  • CAMT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.06% yearly.
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%

3.2 Future

  • CAMT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.24% yearly.
  • The Revenue is expected to grow by 15.15% on average over the next years. This is quite good.
EPS Next Y5.77%
EPS Next 2Y10.58%
EPS Next 3Y12.83%
EPS Next 5Y14.24%
Revenue Next Year6.12%
Revenue Next 2Y10.27%
Revenue Next 3Y13.94%
Revenue Next 5Y15.15%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. CAMT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 45.89 indicates a quite expensive valuation of CAMT.
  • Compared to the rest of the industry, the Price/Earnings ratio of CAMT indicates a somewhat cheap valuation: CAMT is cheaper than 61.74% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.29. CAMT is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 43.39 indicates a quite expensive valuation of CAMT.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CAMT.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, CAMT is valued quite expensively.
Industry RankSector Rank
PE 45.89
Fwd PE 43.39
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CAMT has a very decent profitability rating, which may justify a higher PE ratio.
  • CAMT's earnings are expected to grow with 12.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.96
PEG (5Y)1.21
EPS Next 2Y10.58%
EPS Next 3Y12.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CAMT Dividend Analysis

5.1 Amount

  • No dividends for CAMT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAMT Fundamentals: All Metrics, Ratios and Statistics

CAMTEK LTD

NASDAQ:CAMT (3/6/2026, 8:04:14 PM)

After market: 147.31 0 (0%)

147.31

-17.72 (-10.74%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-18
Earnings (Next)05-11
Inst Owners55.34%
Inst Owner Change-2.77%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap6.75B
Revenue(TTM)496.07M
Net Income(TTM)50.72M
Analysts81.11
Price Target177.31 (20.37%)
Short Float %11.05%
Short Ratio5.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.33
Dividend Growth(5Y)56.74%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.12%
Min EPS beat(2)-2.36%
Max EPS beat(2)0.11%
EPS beat(4)2
Avg EPS beat(4)-1%
Min EPS beat(4)-2.36%
Max EPS beat(4)0.51%
EPS beat(8)6
Avg EPS beat(8)1.58%
EPS beat(12)9
Avg EPS beat(12)2.04%
EPS beat(16)12
Avg EPS beat(16)1.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-0.59%
Revenue beat(8)2
Avg Revenue beat(8)-0.4%
Revenue beat(12)2
Avg Revenue beat(12)-0.58%
Revenue beat(16)2
Avg Revenue beat(16)-0.83%
PT rev (1m)33.8%
PT rev (3m)37.09%
EPS NQ rev (1m)-2.01%
EPS NQ rev (3m)-1.95%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-3.97%
Revenue NQ rev (1m)2.6%
Revenue NQ rev (3m)1.97%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 45.89
Fwd PE 43.39
P/S 13.59
P/FCF N/A
P/OCF N/A
P/B 10.93
P/tB 12.66
EV/EBITDA N/A
EPS(TTM)3.21
EY2.18%
EPS(NY)3.4
Fwd EY2.3%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.84
BVpS13.48
TBVpS11.64
PEG (NY)7.96
PEG (5Y)1.21
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROCE 11.17%
ROIC 8.82%
ROICexc 21%
ROICexgc 25.43%
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
FCFM N/A
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
ROICexc(3y)18.07%
ROICexc(5y)29.31%
ROICexgc(3y)22.71%
ROICexgc(5y)32.19%
ROCE(3y)11.82%
ROCE(5y)12.73%
ROICexgc growth 3Y-9.39%
ROICexgc growth 5Y-5.81%
ROICexc growth 3Y-14.91%
ROICexc growth 5Y-9.14%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
F-ScoreN/A
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.35
Quick Ratio 7.31
Altman-Z 8.96
F-ScoreN/A
WACC12.2%
ROIC/WACC0.72
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
EPS Next Y5.77%
EPS Next 2Y10.58%
EPS Next 3Y12.83%
EPS Next 5Y14.24%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%
Revenue Next Year6.12%
Revenue Next 2Y10.27%
Revenue Next 3Y13.94%
Revenue Next 5Y15.15%
EBIT growth 1Y17.96%
EBIT growth 3Y16.45%
EBIT growth 5Y41.58%
EBIT Next Year10.23%
EBIT Next 3Y14.63%
EBIT Next 5Y18.73%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CAMTEK LTD / CAMT FAQ

What is the fundamental rating for CAMT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CAMT.


What is the valuation status of CAMTEK LTD (CAMT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAMTEK LTD (CAMT). This can be considered as Overvalued.


How profitable is CAMTEK LTD (CAMT) stock?

CAMTEK LTD (CAMT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CAMT stock?

The Price/Earnings (PE) ratio for CAMTEK LTD (CAMT) is 45.89 and the Price/Book (PB) ratio is 10.93.


What is the financial health of CAMTEK LTD (CAMT) stock?

The financial health rating of CAMTEK LTD (CAMT) is 5 / 10.